Cerebrospinal fluid γ-aminobutyric acid and glutamate values in dogs with epilepsy

American Journal of Veterinary Research

Volumn 58, Issue 5, 1997, Pages 451-456

  Podell, Michael ^a   Hadjiconstantinou, Maria ^b  

^a OHIO STATE UNIVERSITY   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; GLUTAMIC ACID DERIVATIVE;

AGING; ANIMAL; ANIMAL DISEASE; ARTICLE; BODY WEIGHT; CEREBROSPINAL FLUID; COMPARATIVE STUDY; DOG; DOG DISEASE; EPILEPSY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INCIDENCE; MALE; METHODOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REGRESSION ANALYSIS; SEXUAL DEVELOPMENT;

AGING; ANIMALS; BODY WEIGHT; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOG DISEASES; DOGS; EPILEPSY; FEMALE; GAMMA-AMINOBUTYRIC ACID; GLUTAMATES; INCIDENCE; MALE; REGRESSION ANALYSIS; SEX CHARACTERISTICS;

EID: 0031135431     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Hauser WA, Hesdorffer DC. Epilepsy: frequency, causes, and consequences. Rockville, Md: Epilepsy Foundation of America, 1990; 197-243.
2. Farnbach GC. Seizures in the dog. Part 1. Basis, classification, and predilection. Compend Contin Educ Pract Vet 1984;6:569-574.
3. Podell M, Fenner WR, Powers JD. Seizure classification in dogs from a nonreferral-based population. J Am Vet Med Assoc 1995; 206:1721-1728.
4. Porter RJ, Rogawski MA. New antiepileptic drugs: from serendipity to rational discovery (review). Epilepsia 1992;33(Suppl 1): S1-6.
5. Engel J. Seizures and epilepsy. Contemporary neurology series. Vol 31. Philadelphia: FA Davis, 1989:536.
6. Lane SB, Bunch SE. Medical management of recurrent seizures in dogs and cats. J Vet Intern Med 1990;4:26-39.
7. Loscher W. Basic aspects of epilepsy (review). Curr Opin Neurol Neurosurg 1993;6:223-232.
8. Jobe PC, Laird HE. Neurotransmitters and epilepsy. Contemporary neurosciences. Clifton, NJ: Humana Press, 1987:366.
9. Meldrum BS. Excitatory amino acid transmitters in epilepsy (review). Epilepsia 1991;32(Suppl 2):S1-3.
10. Snodgrass SR. GABA and epilepsy: their complex relationship and the evolution of our understanding (review). J Child Neurol 1992;7:77-86.
11. Lomax P, Lee RJ, Olsen RW. The spontaneously epileptic Mongolian gerbil. In: Jobe PC, Laird HE, eds. Neurotransmitters in epilepsy. Clifton, NJ: Humana Press, 1987:41-56.
12. Dolina S, Pelling J, Sutherland G, et al. Effect of sustained pyridoxine treatment on seizure susceptibility and regional brain amino acid levels in genetically epilepsy-prone BALB/c mice. Epilepsia 1993;34:33-42.
13. Rainnie DG, Asprodini EK, Shinnickgallagher P. Kindling-induced long lasting changes in synaptic transmission in the basolateral amygdala. J Neurophysiol 1992;67:443-454.
14. Minamato Y, Itano T, Tokuda M, et al. In vivo microdialysis of amino acid neurotransmitters in the hippocampus in amygdaloid kindled rats. Brain Res 1992;573:345-348.
15. Loscher W, Siemes H. Cerebrospinal fluid gamma-aminobutryic acid levels in children with different types of epilepsy: effect of anticonvulsant treatment. Epilepsia 1985;26:314-319.
16. Engelsen B, Elsayed S. Increased concentrations of aspartic acid in the cerebrospinal fluid of patients with epilepsy and trigeminal neuralgia: an effect of medication? Acta Neurol Scand 1984;69: 70-76.
17. Wood JH, Hare TA, Glaeser BS, et al. Low cerebrospinal fluid gamma-aminobutryic acid content in seizure patients. Neurology 1979;29:1203-1208.
18. Loscher W, Schwartz-Porsche D. Low levels of gamma-aminobutyric acid in cerebrospinal fluid of dogs with epilepsy. J Neurochem 1986;46:1322-1325.
19. Chadwick PM, Crawford DW. GABA and amino acid concentrations in lumbar CSF in patients with treated and untreated epilepsy. Epilepsy Res 1987;1:328-338.
20. Ronneengstrom E, Hillered L, Flink R, et al. Intracerebral microdialysis of extracellular amino acids in the human epileptic focus. J Cereb Blood Flow Metab 1992;12:873-876.
21. McDonald JW, Garofalo EA, Hood T, et al. Altered excitatory and inhibitory amino acid receptor binding in hippocampus of patients with temporal lobe epilepsy. Ann Neurol 1991;29:529-541.
22. Rogawski MA. The NMDA receptor, NMDA antagonists and epilepsy therapy. Drugs 1992;44:279-292.
23. Allison LA, Mayer GS, Shoup RE. o-phthalaldehyde derivatives of amines for high-speed liquid chromatography/electrochemistry. Anal Chem 1984;56:1089-1096.
24. Krajnc D, Wemlinger TA, Neff NH, et al. Neonatal hypoxia: early neurotransmitter responses and the consequences of treatment with GM1 ganglioside. J Pharm Exp Ther 1994;271:1299-1305.
25. van Gelder NM, Edmonds HL, Hegreberg GA. Amino acid changes in a genetic strain of epileptic beagle dogs. J Neurochem 1980;35:1087-1091.
26. Farnbach GC. Seizures in the dog. Part II. Control. Compend Contin Educ Pract Vet 1985;7:505-510.
27. Cunningham JC. Inheritance and idiopathic canine epilepsy. J Am Anim Hosp Assoc 1988;24:421-424.
28. Brown SA. Anticonvulsant therapy in small animals. In: Papich MG, ed. Clinical pharmacology. Vol 6. Philadelphia: W B Saunders Co, 1988;1197-1216.
29. Burdette DE, Browne TR. Benzodiazepines. In: Dam M, Gram L, eds. Comprehensive epileptology. New York: Raven Press, 1990:547-561.
30. Horton RW. GABA dysfunction in animal models of epilepsy. In: Tunnicliff G, Raess BU, eds. GABA mechanisms in epilepsy. New York: Wiley-Liss, 1991;121-147.
31. Ross SM, Craig CR. Gamma-aminobutyric acid concentration, L-glutamate 1-decarboxylase activity, and properties of the gamma-aminobutyric acid postsynaptic receptor in cobalt epilepsy in the rat. J Neurosci 1981;1:1388-1396.
32. Griffith NC, Cunningham AM, Goldsmith R, et al. Interictal behavioral alterations and cerebrospinal fluid amino acid changes in a chronic seizure model of temporal lobe of epilepsy. Epilepsia 1991; 32:767-777.
33. Lloyd KG, Scattoni B, Voltz C, et al. Cerebrospinal fluid amino acid and monoamine metabolite levels of Papio papio correlation with photosensitivity. Brain Res 1986;363:390-393.
34. Anlezark G, Collins J, Meldrum BS. GABA agonists and audiogenic seizures. Neurosci Lett 1977;7:337-340.
35. Faingold CL. Seizures induced by convulsant drugs. In: Johe PC, Laird HE, eds. Neurotransmitters in epilepsy. Clifton, NJ: Humana Press, 1987:215-276.
36. Holland KD, McKeon AC, Canney DJ, et al. Relative anticonvulsant effects of GABAmimetic and aGABA modulatory agents. Epilepsia 1992;33:981-986.
37. Meldrum BS, Chapman AG. Benzodiazepine receptors and their relationship to treatment of epilepsy. Epilepsia 1986.27(Suppl 1):S3-S13.
38. Araki K, Harada M, Takino T, et al. Alteration of amino acid content of cerebrospinal fluid from patients with epilepsy. Acta Neurol Scand 1988;78:473-479.
39. Crawford PM, Chadwick DW. GABA and amino acid concentrations in lumber CSF in patients with treated and untreated epilepsy. Epilepsy Res 1987;1:328-338.
40. Pitkanen A, Matilainen R, Halonen T, et al. Inhibitory and excitatory amino acids in cerebrospinal fluid of chronic epileptic patients. J Neural Transm 1989;76:221-30.
41. McGale EHF, Pye IF, Stonier C, et al. Studies of the interrelationship between cerebrospinal fluid and plasma amino acid concentrations in normal individuals. J Neurochem 1977;29:291-297.
42. Maynert EW, Marczynski TJ, Browning RA. The role of neurotransmitters in the epilepsies. Adv Neurol 1975;13:79-147.
43. Lipton SA, Rosenburg PA. Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med 1994;330: 613-622.
44. Whetsell WO. Current concepts of excitotoxicity. J Neuropathol Exp Neurol 1996;55:1-13.
45. Croucher MJ, Collins JF, Meldrum BS. Anticonvulsant action of excitatory amino acid antagonists. Science 1982;216:899-901.
46. Hamberger A. Amino acid disturbances in the neuronal environment-cause or consequence in human epilepsy. Acta Neurol Belg 1990;90:5-10.
47. Akiyama K, Yoneda Y, Ogita K, et al. Ionotropic excitatory amino acid receptors in discrete brain regions of kindled rats. Brain Res 1992;587:73-82.
48. Bohlen P, Huot S, Palfreyman MG. The relationship between GABA concentrations in brain and cerebrospinal fluid. Brain Res 1979;167:297-305.
49. Gale K, Iadarola MJ. GABAergic denervation of the rat substantia nigra: functional and pharmacological properties. Brain Res 1980;183:217-222.
50. Plum CM. Free amino acid levels in the cerebrospinal fluid of normal humans and their variation in cases of epilepsy and Speilmeyer-Vogt-Bauen disease. J Neurochem 1974;23:595-600.
51. Ferrarese C, Pecora N, Frigo M, et al. Assessment of reliability and biological signficance of glutamate levels in cerebrospinal fluid. Ann Neurol 1993;33:316-319.